 | • レポートコード：MRC2-11QY04575 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は発作治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん療法、手術）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別発作治療の競争状況、市場シェア ・世界の発作治療市場：種類別市場規模 2015年-2020年（抗けいれん療法、手術） ・世界の発作治療市場：種類別市場規模予測 2021年-2026年（抗けいれん療法、手術） ・世界の発作治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外来外科センター） ・世界の発作治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来外科センター） ・北米の発作治療市場分析：米国、カナダ ・ヨーロッパの発作治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの発作治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の発作治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの発作治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Cephalon、Novartis、Pfizer、Johnson and Johnson、GlaxoSmithKline、Sanofi、Sunovion Pharmaceuticals、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain.
Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period.
Market Analysis and Insights: Global Seizure Treatments Market
The global Seizure Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Seizure Treatments Scope and Market Size
Seizure Treatments market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Seizure Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Cephalon
Novartis
Pfizer
Johnson and Johnson
GlaxoSmithKline
Sanofi
Sunovion Pharmaceuticals
Bausch Health
Market segment by Type, the product can be split into
Anticonvulsant Therapy
Surgery
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Seizure Treatments Revenue
1.4 Market by Type
1.4.1 Global Seizure Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticonvulsant Therapy
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Seizure Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Seizure Treatments Market Perspective (2015-2026)
2.2 Global Seizure Treatments Growth Trends by Regions
2.2.1 Seizure Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Seizure Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Seizure Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Seizure Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Seizure Treatments Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Seizure Treatments Players by Market Size
3.1.1 Global Top Seizure Treatments Players by Revenue (2015-2020)
3.1.2 Global Seizure Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Seizure Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Seizure Treatments Market Concentration Ratio
3.2.1 Global Seizure Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Seizure Treatments Revenue in 2019
3.3 Seizure Treatments Key Players Head office and Area Served
3.4 Key Players Seizure Treatments Product Solution and Service
3.5 Date of Enter into Seizure Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Seizure Treatments Historic Market Size by Type (2015-2020)
4.2 Global Seizure Treatments Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Seizure Treatments Market Size by Application (2015-2020)
5.2 Global Seizure Treatments Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Seizure Treatments Market Size (2015-2020)
6.2 Seizure Treatments Key Players in North America (2019-2020)
6.3 North America Seizure Treatments Market Size by Type (2015-2020)
6.4 North America Seizure Treatments Market Size by Application (2015-2020)
7 Europe
7.1 Europe Seizure Treatments Market Size (2015-2020)
7.2 Seizure Treatments Key Players in Europe (2019-2020)
7.3 Europe Seizure Treatments Market Size by Type (2015-2020)
7.4 Europe Seizure Treatments Market Size by Application (2015-2020)
8 China
8.1 China Seizure Treatments Market Size (2015-2020)
8.2 Seizure Treatments Key Players in China (2019-2020)
8.3 China Seizure Treatments Market Size by Type (2015-2020)
8.4 China Seizure Treatments Market Size by Application (2015-2020)
9 Japan
9.1 Japan Seizure Treatments Market Size (2015-2020)
9.2 Seizure Treatments Key Players in Japan (2019-2020)
9.3 Japan Seizure Treatments Market Size by Type (2015-2020)
9.4 Japan Seizure Treatments Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Seizure Treatments Market Size (2015-2020)
10.2 Seizure Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Seizure Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Seizure Treatments Market Size by Application (2015-2020)
11 India
11.1 India Seizure Treatments Market Size (2015-2020)
11.2 Seizure Treatments Key Players in India (2019-2020)
11.3 India Seizure Treatments Market Size by Type (2015-2020)
11.4 India Seizure Treatments Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Seizure Treatments Market Size (2015-2020)
12.2 Seizure Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Seizure Treatments Market Size by Type (2015-2020)
12.4 Central & South America Seizure Treatments Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Seizure Treatments Introduction
13.1.4 Abbott Laboratories Revenue in Seizure Treatments Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Cephalon
13.2.1 Cephalon Company Details
13.2.2 Cephalon Business Overview
13.2.3 Cephalon Seizure Treatments Introduction
13.2.4 Cephalon Revenue in Seizure Treatments Business (2015-2020)
13.2.5 Cephalon Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Seizure Treatments Introduction
13.3.4 Novartis Revenue in Seizure Treatments Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Seizure Treatments Introduction
13.4.4 Pfizer Revenue in Seizure Treatments Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Johnson and Johnson
13.5.1 Johnson and Johnson Company Details
13.5.2 Johnson and Johnson Business Overview
13.5.3 Johnson and Johnson Seizure Treatments Introduction
13.5.4 Johnson and Johnson Revenue in Seizure Treatments Business (2015-2020)
13.5.5 Johnson and Johnson Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Seizure Treatments Introduction
13.6.4 GlaxoSmithKline Revenue in Seizure Treatments Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Seizure Treatments Introduction
13.7.4 Sanofi Revenue in Seizure Treatments Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Sunovion Pharmaceuticals
13.8.1 Sunovion Pharmaceuticals Company Details
13.8.2 Sunovion Pharmaceuticals Business Overview
13.8.3 Sunovion Pharmaceuticals Seizure Treatments Introduction
13.8.4 Sunovion Pharmaceuticals Revenue in Seizure Treatments Business (2015-2020)
13.8.5 Sunovion Pharmaceuticals Recent Development
13.9 Bausch Health
13.9.1 Bausch Health Company Details
13.9.2 Bausch Health Business Overview
13.9.3 Bausch Health Seizure Treatments Introduction
13.9.4 Bausch Health Revenue in Seizure Treatments Business (2015-2020)
13.9.5 Bausch Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Seizure Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Seizure Treatments Revenue
Table 3. Ranking of Global Top Seizure Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Seizure Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticonvulsant Therapy
Table 6. Key Players of Surgery
Table 7. Global Seizure Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Seizure Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Seizure Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Seizure Treatments Market Share by Regions (2015-2020)
Table 11. Global Seizure Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Seizure Treatments Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Seizure Treatments Market Growth Strategy
Table 17. Main Points Interviewed from Key Seizure Treatments Players
Table 18. Global Seizure Treatments Revenue by Players (2015-2020) (Million US$)
Table 19. Global Seizure Treatments Market Share by Players (2015-2020)
Table 20. Global Top Seizure Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seizure Treatments as of 2019)
Table 21. Global Seizure Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Seizure Treatments Product Solution and Service
Table 24. Date of Enter into Seizure Treatments Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 27. Global Seizure Treatments Market Size Share by Type (2015-2020)
Table 28. Global Seizure Treatments Revenue Market Share by Type (2021-2026)
Table 29. Global Seizure Treatments Market Size Share by Application (2015-2020)
Table 30. Global Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 31. Global Seizure Treatments Market Size Share by Application (2021-2026)
Table 32. North America Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Seizure Treatments Market Share (2019-2020)
Table 34. North America Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 35. North America Seizure Treatments Market Share by Type (2015-2020)
Table 36. North America Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 37. North America Seizure Treatments Market Share by Application (2015-2020)
Table 38. Europe Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Seizure Treatments Market Share (2019-2020)
Table 40. Europe Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Seizure Treatments Market Share by Type (2015-2020)
Table 42. Europe Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Seizure Treatments Market Share by Application (2015-2020)
Table 44. China Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 45. China Key Players Seizure Treatments Market Share (2019-2020)
Table 46. China Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 47. China Seizure Treatments Market Share by Type (2015-2020)
Table 48. China Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 49. China Seizure Treatments Market Share by Application (2015-2020)
Table 50. Japan Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Seizure Treatments Market Share (2019-2020)
Table 52. Japan Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Seizure Treatments Market Share by Type (2015-2020)
Table 54. Japan Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Seizure Treatments Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Seizure Treatments Market Share (2019-2020)
Table 58. Southeast Asia Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Seizure Treatments Market Share by Type (2015-2020)
Table 60. Southeast Asia Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Seizure Treatments Market Share by Application (2015-2020)
Table 62. India Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 63. India Key Players Seizure Treatments Market Share (2019-2020)
Table 64. India Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 65. India Seizure Treatments Market Share by Type (2015-2020)
Table 66. India Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 67. India Seizure Treatments Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Seizure Treatments Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Seizure Treatments Market Share (2019-2020)
Table 70. Central & South America Seizure Treatments Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Seizure Treatments Market Share by Type (2015-2020)
Table 72. Central & South America Seizure Treatments Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Seizure Treatments Market Share by Application (2015-2020)
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Product
Table 77. Abbott Laboratories Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 78. Abbott Laboratories Recent Development
Table 79. Cephalon Company Details
Table 80. Cephalon Business Overview
Table 81. Cephalon Product
Table 82. Cephalon Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 83. Cephalon Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Johnson and Johnson Company Details
Table 95. Johnson and Johnson Business Overview
Table 96. Johnson and Johnson Product
Table 97. Johnson and Johnson Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 98. Johnson and Johnson Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Product
Table 107. Sanofi Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 108. Sanofi Recent Development
Table 109. Sunovion Pharmaceuticals Business Overview
Table 110. Sunovion Pharmaceuticals Product
Table 111. Sunovion Pharmaceuticals Company Details
Table 112. Sunovion Pharmaceuticals Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 113. Sunovion Pharmaceuticals Recent Development
Table 114. Bausch Health Company Details
Table 115. Bausch Health Business Overview
Table 116. Bausch Health Product
Table 117. Bausch Health Revenue in Seizure Treatments Business (2015-2020) (Million US$)
Table 118. Bausch Health Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seizure Treatments Market Share by Type: 2020 VS 2026
Figure 2. Anticonvulsant Therapy Features
Figure 3. Surgery Features
Figure 4. Global Seizure Treatments Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Seizure Treatments Report Years Considered
Figure 9. Global Seizure Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Seizure Treatments Market Share by Regions: 2020 VS 2026
Figure 11. Global Seizure Treatments Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Seizure Treatments Market Share by Players in 2019
Figure 14. Global Top Seizure Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seizure Treatments as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Seizure Treatments Revenue in 2019
Figure 16. North America Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Seizure Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
大発作の世界市場（～2026年） Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic …- 瘢痕併用療法の世界市場（～2026年） Scar treatment is a technique that is utilized to limit the scars marks so that it seem more consistent with the skin tone and surface surrounding. Scars are marks that stay after a wound recovers and unavoidable aftereffects of damage or surgery. Scars are of different types, which includes keloid …
- 帯状疱疹治療の世界市場（～2026年） Shingles is a viral disease characterized by a painful skin rash with blisters in a localized area. The shingles treatment market is expected to witness a high growth over the forecast period owing to the increasing prevalence of shingles. Market Analysis and Insights: Global Shingles Treatments Mar…
- 統合失調症治療の世界市場（～2026年） Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. Market Analysis and Insights: Global Schizophr…
- 脳腫瘍診断・治療の世界市場（～2026年） With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical exposure, the demand of Diagnosis and treatment of brain tumors is increasing. Market Analysis and Insights: Global Brain Tumor Diagnosis and Treatments Market The global Brain Tumo…